Trump Threatens With a 200% Tariff – and big Pharma Responds Calmly
Reading Time: 3 minutes
When a US president announces tariffs of 200% on imported medicines, it initially sounds like a nightmare for the pharmaceutical industry. However, the stock market's reaction is surprisingly calm: while the broader market barely moved over the week, the NYSE Arca Pharmaceutical Index managed to gain about 1%. A paradoxical picture – but upon closer inspection, a certain logic reveals itself. Grace period instead of shock reaction Donald Trump declared on Tuesday that pharmaceutical companies can expect a generous transition period: "We're...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
